FDA Advisory Committee supports use of tobramycin inhalation powder from Novartis for patients with cystic fibrosis

FDA Advisory Committee supports use of tobramycin inhalation powder from Novartis for patients with cystic fibrosis

Sep 05, 2012
Source URL: https://qa1.novartis.us/news/media-releases/fda-advisory-committee-supports-use-tobramycin-inhalation-powder-from-novartis-patients-cystic-fibrosis-0

List of links present in page
  1. https://qa1.novartis.us/news/media-releases/fda-advisory-committee-supports-use-tobramycin-inhalation-powder-from-novartis-patients-cystic-fibrosis-0